FindTrial
Sign In

Study on the Mechanism of Human Umbilical Cord Blood Serum in Anti-renal Fibrosis

Study on the Mechanism of Human Umbilical Cord Blood Serum in Anti-renal Fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111523
Enrollment
Unknown
Registered
2025-11-01
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal fibrosis

Interventions

Observation Group of Residual Umbilical Cord Blood of Healthy Parturients:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Healthy pregnant women aged 20 to 50 2. Agree to store the umbilical cord blood and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Age less than 20 years old or over 50 years old; 2. Having a history of kidney disease; 3. Severe dysfunction of heart, lungs or brain; 4. Complicated with pregnancy-related emergencies: such as pregnancy-related hypertension, eclampsia or preeclampsia; 5. Acute infection, malignant tumor; 6. Refusing to store umbilical cord blood or refusing to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
The result of umbilical cord serum test;—

Countries

China

Contacts

Public ContactWang Ling

Shanghai Tenth People's Hospital

nowax@tongji.edu.cn+86 21 6630 2527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026